BB BIOTECH AG

Holdings History for Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE)

Symbol: SAGE
Investment type: Equity / Common Stock, par value $0.0001 per share (the "Common Stock")
Latest Disclosed Shares Owned: 1,178,503 shares
Security Ownership %: 1.9%

Shares, Excluding Options vs Price

Value, Excluding Options

BB Biotech AG ownership in Sage Therapeutics, Inc. Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE)

17 Jan 2025 - BB Biotech AG has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,178,503 shares of Sage Therapeutics, Inc. Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE). This represents 1.9% ownership of the company. This is the first filing by BB BIOTECH AG disclosing ownership of Sage Therapeutics, Inc. Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
BB Biotech AG	1.9%		$9,180,538	1,178,503			$7.79	13G/A	13 Jan 2025	17 Jan 2025, 06:02

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Mar 2019	5.5%	0%	$218,730,000	1,375,229	0		$159.05	Q1 2019
31 Dec 2018	4.2%	+0.93%	$131,733,000	1,375,229	+303,856	+28%	$95.79	Q4 2018
30 Sep 2018	4%	0%	$151,331,000	1,071,373	0		$141.25	Q3 2018
30 Jun 2018	4.8%	+0.31%	$167,702,000	1,071,373	+68,934	+6.9%	$156.53	Q2 2018
31 Mar 2018	4.5%	-0.18%	$161,463,000	1,002,439	-40,000	-3.8%	$161.07	Q1 2018
31 Dec 2017	4.8%	-0.23%	$171,700,000	1,042,439	-50,000	-4.6%	$164.71	Q4 2017
30 Sep 2017	1.9%	+0.32%	$68,059,000	1,092,439	+185,000	+20%	$62.30	Q3 2017
30 Jun 2017	2.2%	-0.16%	$72,268,000	907,439	-65,000	-6.7%	$79.64	Q2 2017
31 Mar 2017	2.3%	-0.12%	$69,111,000	972,439	-50,000	-4.9%	$71.07	Q1 2017
31 Dec 2016	1.9%	0%	$52,206,000	1,022,439	0		$51.06	Q4 2016
30 Sep 2016	1.7%	+0.28%	$47,083,000	1,022,439	+171,800	+20%	$46.05	Q3 2016
30 Jun 2016	1%	+0.02%	$25,630,000	850,639	+16,976	+2%	$30.13	Q2 2016
31 Mar 2016	1.1%	+0.16%	$26,727,000	833,663	+125,000	+18%	$32.06	Q1 2016
31 Dec 2015	1.2%	+1.2%	$41,315,000	708,663	+708,663	NEW	$58.30	Q4 2015

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.